BPC-157
BPC-157 (Body Protective Compound 157) is a synthetic pentadecapeptide derived from human gastric juice. It demonstrates remarkable tissue repair properties across tendons, ligaments, muscles, and gut lining in preclinical research.
Where to Buy
BPC-157 is a 15-amino-acid peptide fragment derived from body protection compound found in human gastric juice. It has shown consistent wound healing, anti-inflammatory, and tissue regeneration effects across dozens of animal studies.
The peptide promotes angiogenesis (new blood vessel formation), which is critical for healing damaged tissues. It also upregulates growth hormone receptors and modulates nitric oxide synthesis.
While human clinical trials are limited, BPC-157 has an extensive preclinical research base and a long history of use in the research community. It is generally considered to have a favorable safety profile in animal models.
Dosing Reference
| Beginner Dose | 200–250 mcg/day |
| Standard Dose | 400–500 mcg/day |
| Frequency | Once or twice daily subcutaneous or intramuscular injection |
| Cycle Duration | 4–12 weeks |
Note: Injecting near the injury site is commonly used in research protocols. Oral and nasal administration also studied but injectable shows strongest effects.
Mechanism of Action
BPC-157 promotes healing through multiple pathways: it stimulates VEGF (vascular endothelial growth factor) expression for angiogenesis, upregulates growth hormone receptor expression, modulates the NO system, and has anti-inflammatory effects through inhibition of inflammatory cytokines.
Side Effects
| Effect | Severity |
|---|---|
| Injection site discomfort | mild |
| Nausea (oral form) | mild |
| Dizziness (reported anecdotally) | mild |
Research use only. All content on The Peptide Primer is provided for educational and informational purposes only. Nothing on this site constitutes medical advice. Peptides discussed are not FDA-approved for human use unless otherwise noted. Always consult a qualified healthcare professional before making health-related decisions.